Rina Leyva

Pfizer (United States)

Research Areas

• Inflammatory mediators and NSAID effects
• Liver Disease Diagnosis and Treatment
• Drug-Induced Hepatotoxicity and Protection
• Liver Diseases and Immunity
• Thermal Regulation in Medicine

Papers (1)

• 2017
  Selective method for identification and quantification of Bifidobacterium animalis subspecies lactis BB‐12 (BB‐12) from the gastrointestinal tract of healthy volunteers ingesting a combination probiotic of BB‐12 and Lactobacillus rhamnosus GG10.1111/jam.13436